In re Rosuvastatin Calcium Patent Litigation

NOTE: This order is nonprecedential

United States Court of AppeaIs for the FederaI Circuit

IN RE ROSUVASTATIN CALCIUM PATENT

LITIGATION

ASTRAZENECA UK LIMITED,

IPR PHARMACEUTICALS INC.,

AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs-Appellees,

V.

AUROBINDO PHARMA LIMITED,

Defen,dcmt-Appellant,

AND

MYLAN PHARMACEUTICALS INC.,

Defendant-Appellan,t,

AND

APOTEX CORP.,

Defendant-Appellant,

AND

COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC.,

Defendan,ts-Appellan,ts,

AND

SUN PHARMACEUTICAL INDUSTRIES, LTD.,

Defen,dant-Appellant,

ASTRAZEN`ECA PHA.RMA V. AUROBINDO 2

AND

TEVA PHARMACEUTICALS USA, INC.,

Defendan,t-Appellant,

AND

PAR PHARMACEUTICAL, INC.,

Defendant-Appellan,t,

AND

SANDOZ, INC.,

Defen,dant.

2010-1460, -1461, -1462, -1463, -i464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 Appeals from the United States District Court for the District of De1aWare in case nos. 08-MD-1949, O'7-CV- O81O, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07~CV-0806, O8~CV-0426, and 07-CV-0808, Judge Joseph J. Farnan, Jr.

ON MOTION

ORDER

Upon consideration of Apotex, Inc., AstraZeneca Phar- maceutica1S LP and Aurobind0 Pharma USA Inc.’s unop- posed motion to be removed as parties in the caption, IT IS ORDERED THAT2

The motions are granted The revised official caption is reflected above. cc.

S

ASTRAZENECA PHABMA V. AUROBINDO

FoR THE C0URT

0 9 /s/ Jan Horba1y

Date J an Horbaly

Charles E. Lipsey, Esq.

R0bert B. Breisb1att, Esq.

Jeffrey S. Ward, Esq.

Steven A. Maddox, Esq.

Wil1iam A. Rakoczy, Esq.

Dutch Chung, Esq.

J ames F. Hurst, Esq.

Richard A. Kap1an, Esq.

C1erk

Fl u.s. c0uR‘r 0llFE\PPzALs ron

Tl-us FEoERAL clncurr

SEP 0 9 -2019

JAN HORBALY

CLERK